Genome Editing for Neurodegenerative Diseases: From Concept to Clinical Trials examines recent advances in neurodegenerative disease research and clinical challenges in practical applications. With an emphasis on genome editing tools such as ZFNs, TALENSs and CRISPR-Cas, this book sheds light on the possibilities to counteract genetic and neurodegenerative diseases. It will be of interest to researchers in neuroscience and biopharmaceuticals, as well as clinicians specializing in neurodegenerative diseases.
Genome Editing for Neurodegenerative Diseases: From Concept to Clinical Trials examines recent advances in neurodegenerative disease research and clinical challenges in practical applications. With an emphasis on genome editing tools such as ZFNs, TALENSs and CRISPR-Cas, this book sheds light on the possibilities to counteract genetic and neurodegenerative diseases. It will be of interest to researchers in neuroscience and biopharmaceuticals, as well as clinicians specializing in neurodegenerative diseases.Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
Introduction Burkhard Poeggeler 1. Therapeutic potential of genome editing tools in neurodegenerative diseases Ankur Kumar Nandigam Pardhipa Sachin G. Swami Vibha Dwivedi and Anand K. Singh 2. Genetic and molecular basis of neurodegenerative diseases Sunanda Yogi Anjali Sangeeth Anuradha Venkatakrishnan Chimata Radhika Padma and Amit Singh 3. Genome editing tools: principles structures and mechanisms Rayees Ahmad Naik Mehak Naseer Mir Roshni Rajpoot Sonalika Singh Kusum Singh and Sandeep Kumar Singh 4. Advances in CRISPER/Cas system and genome editing technologies for the treatment of neurodegenerative diseases Shailendra Kumar Mishra Hung-Ming Chang Ahmad A. Obaid and Sandeep Kumar Singh 5. Use of CRISPR system in genetic screening to detect neurodegenerative disease Koyel Kar 6. Epigenetic manipulation and gene regulation using the CRISPR/Cas system for neurodegenerative diseases Josephine Esposto 7. Transgene delivery system: viral nonviral and other methods for central nervous system Bhupender Sahu Bibhudendu Behera and Umesh Kumar 8. Gene therapies for neurodegenerative disease: current knowledge and challenges Bhumi Arora Sakshi Garg Aditya Shrivastav Mrinalini Sharma Bhupender Sahu and Umesh Kumar 9. Gene therapy under clinical trials for neurodegenerative diseases Bhupender Sahu Lakshita Tyagi Prshant Tyagi and Umesh Kumar 10. Clinical challenges and future prospective in use of gene-editing tools as neurotherapeutics Burkhard Poeggeler
Introduction Burkhard Poeggeler 1. Therapeutic potential of genome editing tools in neurodegenerative diseases Ankur Kumar Nandigam Pardhipa Sachin G. Swami Vibha Dwivedi and Anand K. Singh 2. Genetic and molecular basis of neurodegenerative diseases Sunanda Yogi Anjali Sangeeth Anuradha Venkatakrishnan Chimata Radhika Padma and Amit Singh 3. Genome editing tools: principles structures and mechanisms Rayees Ahmad Naik Mehak Naseer Mir Roshni Rajpoot Sonalika Singh Kusum Singh and Sandeep Kumar Singh 4. Advances in CRISPER/Cas system and genome editing technologies for the treatment of neurodegenerative diseases Shailendra Kumar Mishra Hung-Ming Chang Ahmad A. Obaid and Sandeep Kumar Singh 5. Use of CRISPR system in genetic screening to detect neurodegenerative disease Koyel Kar 6. Epigenetic manipulation and gene regulation using the CRISPR/Cas system for neurodegenerative diseases Josephine Esposto 7. Transgene delivery system: viral nonviral and other methods for central nervous system Bhupender Sahu Bibhudendu Behera and Umesh Kumar 8. Gene therapies for neurodegenerative disease: current knowledge and challenges Bhumi Arora Sakshi Garg Aditya Shrivastav Mrinalini Sharma Bhupender Sahu and Umesh Kumar 9. Gene therapy under clinical trials for neurodegenerative diseases Bhupender Sahu Lakshita Tyagi Prshant Tyagi and Umesh Kumar 10. Clinical challenges and future prospective in use of gene-editing tools as neurotherapeutics Burkhard Poeggeler
Es gelten unsere Allgemeinen Geschäftsbedingungen: www.buecher.de/agb
Impressum
www.buecher.de ist ein Internetauftritt der buecher.de internetstores GmbH
Geschäftsführung: Monica Sawhney | Roland Kölbl | Günter Hilger
Sitz der Gesellschaft: Batheyer Straße 115 - 117, 58099 Hagen
Postanschrift: Bürgermeister-Wegele-Str. 12, 86167 Augsburg
Amtsgericht Hagen HRB 13257
Steuernummer: 321/5800/1497
USt-IdNr: DE450055826
